Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapy.

Saved in:
Bibliographic Details
Title: Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapy.
Authors: Morgan D; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.; The University of Kansas Cancer Center, Kansas City, KS, 66160, USA., Schueddig E; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, 66160, USA., Segura A; Department of Dermatology, University of New Mexico School of Medicine, University of New Mexico Hospital, Albuquerque, NM, 87131, USA., Bodine T; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, 66160, USA., Lominska C; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, 66160, USA., Morse RT; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, 66160, USA., Neupane P; Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Kansas City, KS, 66160, USA., Pei D; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, 66160, USA.; The University of Kansas Cancer Center, Kansas City, KS, 66160, USA., Koestler D; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, 66160, USA.; The University of Kansas Cancer Center, Kansas City, KS, 66160, USA., Kimple R; Department of Human Oncology, University of Wisconsin, Madison, WI, 53705, USA., Duvvuri U; Department of Otolaryngology-Head and Neck Surgery, New York University Grossman School of Medicine, New York City, NY, 10032, USA., Thomas S; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.; The University of Kansas Cancer Center, Kansas City, KS, 66160, USA., Nallani R; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, KS, 66160, USA., Shnayder L; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, KS, 66160, USA., Kakarala K; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, KS, 66160, USA., Bur AM; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, KS, 66160, USA., Yilmaz E; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, 44195, USA., Gan GN; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.; The University of Kansas Cancer Center, Kansas City, KS, 66160, USA.
Source: Oral oncology reports [Oral Oncol Rep] 2026 Mar; Vol. 17. Date of Electronic Publication: 2026 Jan 06.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918681183706676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-9060 (Electronic) Linking ISSN: 27729060 NLM ISO Abbreviation: Oral Oncol Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2772-9060
DOI:10.1016/j.oor.2025.100780